THC Global Group Limited (ASX:THC) Quarterly Update & Appendix 4C
THC Global Group Limited (ASX:THC) is pleased to provide an update on the Company's activities, as well as the Appendix 4C for the quarter ended 30 June 2019.
THC Global Group Limited (ASX:THC) is pleased to provide an update on the Company's activities, as well as the Appendix 4C for the quarter ended 30 June 2019.
Anatara Lifesciences (ASX:ANR) is pleased to release to investors a copy of the presentation that Chief Executive Officer, Mr Steven Lydeamore, presented at the 15th Bioshares Biotech Summit, held in Queenstown, New Zealand, 26th to 27th July 2019.
Anatara Lifesciences Ltd (ASX:ANR) is pleased to release its Appendix 4C for the quarter ending 30th June 2019. The Company's cash plus term deposits at the end of the quarter stood at $5.4m. On 30th June 2019, the Company had cash at bank of $1,360,086 and $4,050,000 in term deposits. Expenditure during the quarter was in line with forecast.
Anatara's CEO, Steve Lydeamore will be presenting to investors during the Bioshares Biotech Summit this Friday, and at a Monsoon Communications Twilight Investor Briefing event in Melbourne during August.
VIDEO: MMJ Holdings Ltd (ASX:MMJ) (FRA:2P9) (OTCMKTS:MMJJF) Michael Curtis, Non-Executive Director, is interviewed by Commsec's Tom Piotrowski. Michael Curtis is also Managing Director of Embark Ventures.
VIDEO: MMJ Holdings Ltd (ASX:MMJ) (FRA:2P9) (OTCMKTS:MMJJF) Interview with Proactive Investors. Michael Curtis a Non-Executive Director of MMJ, as well as Managing Director of Embark Ventures.
MMJ Group Holdings Limited (ASX:MMJ) (FRA:2P9) (OTCMKTS:MMJJF), an Australian-listed company that specialises in managing a portfolio of investments along the cannabis value-chain, has agreed to invest CAD2.5m in the privately-held Sequoya Cannabis Limited ("Sequoya").